/Investor DB

HealthCap — 2021 Investments

2 investments dated 2021 · listed companies and verified rows first · show all

Oncorenaoncorena.cominDec 2021 · $7M✓ verified

Oncorena is a Swedish pharmaceutical company developing a breakthrough treatment for metastatic renal cancer based on the drug candidate ONC175 (orellanine).

BiotechHealthtechMedical DevicesStockholm, SE

Börje Haraldsson(Research lead)inJenny NyströminUlf NilssonLisa BuvallinPål FalckinSusanna Dahlgren(Chief Operating Officer)in

Co-investorsFSGGU Ventures AB

Adcendoadcendo.dkSeries A · Apr 2021 · $62M

Adcendo develops antibody-drug conjugates (ADCs) engineered to treat cancers with high unmet medical needs.

BiotechDigital HealthMedical Devices

Co-investorsVida VenturesJeito CapitalYsios Capital

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.